BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25911687)

  • 1. Cell- and molecular-level mechanisms contributing to diastolic dysfunction in HFpEF.
    Campbell KS; Sorrell VL
    J Appl Physiol (1985); 2015 Nov; 119(10):1228-32. PubMed ID: 25911687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.
    Hamdani N; Bishu KG; von Frieling-Salewsky M; Redfield MM; Linke WA
    Cardiovasc Res; 2013 Mar; 97(3):464-71. PubMed ID: 23213108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.
    Zile MR; Baicu CF; Ikonomidis JS; Stroud RE; Nietert PJ; Bradshaw AD; Slater R; Palmer BM; Van Buren P; Meyer M; Redfield MM; Bull DA; Granzier HL; LeWinter MM
    Circulation; 2015 Apr; 131(14):1247-59. PubMed ID: 25637629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Load-Independent Systolic and Diastolic Right Ventricular Function in Heart Failure With Preserved Ejection Fraction as Assessed by Resting and Handgrip Exercise Pressure-Volume Loops.
    Rommel KP; von Roeder M; Oberueck C; Latuscynski K; Besler C; Blazek S; Stiermaier T; Fengler K; Adams V; Sandri M; Linke A; Schuler G; Thiele H; Lurz P
    Circ Heart Fail; 2018 Feb; 11(2):e004121. PubMed ID: 29449367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
    Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxation and the Role of Calcium in Isolated Contracting Myocardium From Patients With Hypertensive Heart Disease and Heart Failure With Preserved Ejection Fraction.
    Runte KE; Bell SP; Selby DE; Häußler TN; Ashikaga T; LeWinter MM; Palmer BM; Meyer M
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28784688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction.
    Michalski B; Trzciński P; Kupczyńska K; Miśkowiec D; Pęczek Ł; Nawrot B; Lipiec P; Kasprzak JD
    Cardiol J; 2017; 24(1):35-42. PubMed ID: 27748500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure with preserved ejection fraction: refocusing on diastole.
    Abbate A; Arena R; Abouzaki N; Van Tassell BW; Canada J; Shah K; Biondi-Zoccai G; Voelkel NF
    Int J Cardiol; 2015 Jan; 179():430-40. PubMed ID: 25465302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.
    Valero-Muñoz M; Li S; Wilson RM; Hulsmans M; Aprahamian T; Fuster JJ; Nahrendorf M; Scherer PE; Sam F
    Circ Heart Fail; 2016 Jan; 9(1):e002724. PubMed ID: 26721917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
    Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial hypertrophy and its role in heart failure with preserved ejection fraction.
    Heinzel FR; Hohendanner F; Jin G; Sedej S; Edelmann F
    J Appl Physiol (1985); 2015 Nov; 119(10):1233-42. PubMed ID: 26183480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function.
    Rosas PC; Liu Y; Abdalla MI; Thomas CM; Kidwell DT; Dusio GF; Mukhopadhyay D; Kumar R; Baker KM; Mitchell BM; Powers PA; Fitzsimons DP; Patel BG; Warren CM; Solaro RJ; Moss RL; Tong CW
    Circ Heart Fail; 2015 May; 8(3):582-94. PubMed ID: 25740839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis.
    Penicka M; Bartunek J; Trakalova H; Hrabakova H; Maruskova M; Karasek J; Kocka V
    J Am Coll Cardiol; 2010 Apr; 55(16):1701-10. PubMed ID: 20394874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Kumar AA; Kelly DP; Chirinos JA
    Circulation; 2019 Mar; 139(11):1435-1450. PubMed ID: 30856000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empagliflozin directly improves diastolic function in human heart failure.
    Pabel S; Wagner S; Bollenberg H; Bengel P; Kovács Á; Schach C; Tirilomis P; Mustroph J; Renner A; Gummert J; Fischer T; Van Linthout S; Tschöpe C; Streckfuss-Bömeke K; Hasenfuss G; Maier LS; Hamdani N; Sossalla S
    Eur J Heart Fail; 2018 Dec; 20(12):1690-1700. PubMed ID: 30328645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.